
PD-042 Induction (I) or consolidation (C) chemotherapy withdocetaxel (D) and gemcitabine (G) plus concomitant chemoradiotherapy (CT/TRT) with docetaxel and carboplatin (Cb) for unresectable stage III non-small cell lung cancer (NSCLC) patients (p). Initial report of the randomized phase II trial SLCG 0008
Garrido, P., Resell, R., Arellano, A., Ramos, A., Massuti, T., Andreu, J., Cardenal, F., Arnaiz, A., Amador, M., Alberola, V.Volume:
49
Langue:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80375-7
Date:
July, 2005
Fichier:
PDF, 148 KB
english, 2005